DK342684A - Vandige proteinoploesninger, som er bestandige over for denaturering, fremgangsmaade til deres fremstilling og deres anvendelse - Google Patents

Vandige proteinoploesninger, som er bestandige over for denaturering, fremgangsmaade til deres fremstilling og deres anvendelse Download PDF

Info

Publication number
DK342684A
DK342684A DK342684A DK342684A DK342684A DK 342684 A DK342684 A DK 342684A DK 342684 A DK342684 A DK 342684A DK 342684 A DK342684 A DK 342684A DK 342684 A DK342684 A DK 342684A
Authority
DK
Denmark
Prior art keywords
denaturing
preparation
procedure
formula
protein solutions
Prior art date
Application number
DK342684A
Other languages
English (en)
Other versions
DK342684D0 (da
DK168030B1 (da
Inventor
Horst Thurow
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK342684D0 publication Critical patent/DK342684D0/da
Publication of DK342684A publication Critical patent/DK342684A/da
Application granted granted Critical
Publication of DK168030B1 publication Critical patent/DK168030B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK342684A 1983-07-13 1984-07-12 Vandige proteinoploesninger, som er bestandige over for denaturering, fremgangsmaade til deres fremstilling og deres anvendelse samt fremgangsmaade til behandling af hydrophobe overflader. DK168030B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3325223 1983-07-13
DE19833325223 DE3325223A1 (de) 1983-07-13 1983-07-13 Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung

Publications (3)

Publication Number Publication Date
DK342684D0 DK342684D0 (da) 1984-07-12
DK342684A true DK342684A (da) 1985-01-14
DK168030B1 DK168030B1 (da) 1994-01-24

Family

ID=6203842

Family Applications (1)

Application Number Title Priority Date Filing Date
DK342684A DK168030B1 (da) 1983-07-13 1984-07-12 Vandige proteinoploesninger, som er bestandige over for denaturering, fremgangsmaade til deres fremstilling og deres anvendelse samt fremgangsmaade til behandling af hydrophobe overflader.

Country Status (15)

Country Link
US (1) US4637834A (da)
EP (1) EP0131864B1 (da)
JP (1) JPS6038398A (da)
KR (1) KR920002934B1 (da)
AT (1) ATE56876T1 (da)
AU (1) AU579106B2 (da)
DE (2) DE3325223A1 (da)
DK (1) DK168030B1 (da)
ES (2) ES8600319A1 (da)
FI (1) FI80276C (da)
GR (1) GR81504B (da)
IE (1) IE57694B1 (da)
IL (1) IL72389A (da)
PT (1) PT78892A (da)
ZA (1) ZA845384B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US4956274A (en) * 1987-04-06 1990-09-11 Microgenics Corporation Reagent stabilization in enzyme-donor and acceptor assay
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
US5830452A (en) * 1990-11-20 1998-11-03 Chiron Corporation Method for enhancing the anti-tumor therapeutic index of interleukin-2
JPH08502021A (ja) * 1992-04-07 1996-03-05 マリンクロッド・ヴェタラネリィ・インコーポレイテッド 生体相容性ソマトトロピン溶液
DK0955062T3 (da) † 1992-07-31 2007-09-17 Genentech Inc Vandig formulering indeholdende humant væksthormon
US6790439B1 (en) 1995-06-07 2004-09-14 Zymogenetics, Inc. Thrombopoietin compositions
CA2223745C (en) * 1995-06-07 2004-03-16 Chiron Corporation Method of solubilizing, purifying, and refolding protein
MX9602398A (es) * 1995-06-23 1997-02-28 Kimberly Clark Co Material polimerico modificado teniendo humectabilidad mejorada.
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
CN1360506A (zh) * 1999-07-12 2002-07-24 格兰迪斯生物技术有限公司 生长激素配方
EP1536835A1 (en) * 2002-07-09 2005-06-08 Sandoz AG Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol
WO2005019265A1 (en) * 2003-08-13 2005-03-03 Chiron Corporation Improved method of purifying tfpi and tfpi analogs
BRPI0508798A (pt) 2004-04-07 2007-09-04 Ares Trading Sa formulação lìquida de hormÈnio de crescimento, composição farmacêutica, forma de apresentação da formulação lìquida de hormÈnio de crescimento e uso da formulação lìquida de hormÈnio de crescimento
EP1847830A1 (en) * 2006-04-20 2007-10-24 TF Instruments, Inc. Determining optimal concentrations of protective additives for biomolecules
WO2024133849A1 (en) * 2022-12-22 2024-06-27 The Protein Brewery B.V. Ovalbumin fermentation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439355A (en) * 1976-12-02 1984-03-27 Colgate-Palmolive Company Elastic detergent product of improved foaming power after use
DE2917535C2 (de) * 1979-04-30 1986-10-30 Hoechst Ag, 6230 Frankfurt Gegen Denaturierung beständige Insulinlösungen
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
EP0083619A1 (en) * 1981-07-17 1983-07-20 Nordisk Insulinlaboratorium A stable aqueous, therapeutic insulin preparation and a process for preparing it

Also Published As

Publication number Publication date
ES8609361A1 (es) 1986-09-01
ATE56876T1 (de) 1990-10-15
EP0131864B1 (de) 1990-09-26
DE3483287D1 (de) 1990-10-31
JPS6038398A (ja) 1985-02-27
ES535482A0 (es) 1986-09-01
EP0131864A3 (en) 1987-08-26
GR81504B (da) 1984-12-11
AU3053784A (en) 1985-01-17
DK342684D0 (da) 1984-07-12
AU579106B2 (en) 1988-11-17
FI80276C (fi) 1990-05-10
PT78892A (de) 1984-08-01
IL72389A (en) 1988-11-30
FI80276B (fi) 1990-01-31
ES534195A0 (es) 1985-10-01
DK168030B1 (da) 1994-01-24
KR920002934B1 (ko) 1992-04-10
KR850000971A (ko) 1985-03-14
FI842798A0 (fi) 1984-07-11
ZA845384B (en) 1985-02-27
IE841796L (en) 1985-01-13
FI842798A7 (fi) 1985-01-14
US4637834A (en) 1987-01-20
IL72389A0 (en) 1984-11-30
DE3325223A1 (de) 1985-01-24
EP0131864A2 (de) 1985-01-23
ES8600319A1 (es) 1985-10-01
IE57694B1 (en) 1993-03-10
JPH0582397B2 (da) 1993-11-18

Similar Documents

Publication Publication Date Title
DK342684A (da) Vandige proteinoploesninger, som er bestandige over for denaturering, fremgangsmaade til deres fremstilling og deres anvendelse
DK0741694T3 (da) Phenyleddikesyrederivater, fremgangsmåder og mellemprodukter til deres fremstilling og midler indeholdende disse
NZ220546A (en) Benzothiophene- and benzofuran- amides and compositions
DK520784D0 (da) Cycliske polypeptider, deres fremstilling og anvendelse
DK359387D0 (da) Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling
DK629889D0 (da) Aminosyrederivater, deres fremstilling og anvendelse som laegemidler
DK0735083T3 (da) Enaminer som vulkaniseringsacceleratorer til naturlige eller syntetiske gummier
AU1721883A (en) Muramyl peptides
AU1779188A (en) Guanidine-related compounds comprising a substituted tetraphenylborate ion, process for obtaining these compounds, and use of the compounds
ES2170946T3 (es) Procedimiento de preparacion de compuestos fluorados a partir de las aminas correspondientes.
DK640687A (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
DK283289D0 (da) Phenothiazinderivater, deres fremstilling og farmaceutiske praeparater deraf
DE59500764D1 (de) Verfahren zur Herstellung von Cyanimino-1,3-thiazolidinen
DK214589A (da) 3-substituerede 3-(thien-2-yl)-piperazin-2-oner eller farmakologisk acceptable syreadditionsforbindelser deraf, deres fremstilling og anvendelse
ES2043784T3 (es) Procedimiento de preparacion de compuestos guanidinicos.
ATE111087T1 (de) Verfahren zur herstellung von 2-aryl-2h-1,2,3- triazolen.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired